NCT07260175 2026-02-23
adIVO
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Recruiting
Clinical Trials
4 trialsNCT05876754 2026-02-19
ProvIDHe
Servier
Phase 3 Recruiting
NCT02989857 2024-08-20
ClarIDHy
Servier
Phase 3 Completed
NCT04088188 2024-05-06
Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma
Academic and Community Cancer Research United
Phase 1 Terminated